Anti-VEGF therapies for age-related macular degeneration: a powerful tactical gear or a blunt weapon? The choice is ours.

Paolo Lanzetta

Published in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2021)

This review shows that by implementing existing health care systems and dispensing adequate therapies in the field of retinal diseases, the prevalence of blindness due to these conditions can decline.

Keyphrases

age related macular degeneration
healthcare
optical coherence tomography
risk factors
vascular endothelial growth factor
diabetic retinopathy
endothelial cells
quality improvement
optic nerve
decision making